Skip to content

Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based Formulas With Different Fat Blends

Comparative Calcium Absorption and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-based Formulas With Different Fat Blends

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00941564
Enrollment
33
Registered
2009-07-17
Start date
2010-03-31
Completion date
2010-05-31
Last updated
2010-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant

Brief summary

The objective is to assess the comparative calcium absorption and gastrointestinal (GI) tolerance in healthy normal term infants fed two commercially available powdered milk-based formulas which contain different fat blends.

Interventions

OTHERInfant Formula milk based

Consume ad lib

OTHERInfant formula milk based

consume ad lib

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
84 Days to 159 Days
Healthy volunteers
Yes

Inclusion criteria

* Infant in good health, full term, singleton birth and 84-156 days of age at enrollment. Male infants only to be enrolled for primary variable measures. * Restrict use of certain medications or home remedies, herbal preparations, probiotics or rehydration/intravenous (IV) fluids.

Exclusion criteria

* Adverse maternal, fetal or infant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development. * Infant has been treated with antibiotics 3 days prior to enrollment. * Infant has received probiotics-containing products 3 days prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Calcium absorption18 days

Secondary

MeasureTime frame
Calcium retention, fat absorption, tolerance18 days

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026